Effects of ertugliflozin monotherapy or combination therapy on glycaemic control, body weight, and blood pressure in patients with type 2 diabetes: a pooled analysis

被引：0
|
作者：
Lauring, B. [1 ]
Liu, J. [1 ]
Tarasenko, L. [2 ]
Terra, S. G. [3 ]
Huyck, S. [1 ]
Wu, L. [1 ]
Pong, A. [1 ]
Calle, R. A. [4 ]
Gallo, S. [5 ]
Darekar, A. [6 ]
Mancuso, J. P. [7 ]
机构：
[1] Merck & Co Inc, Kenilworth, NJ USA
[2] Pfizer Inc, New York, NY USA
[3] Pfizer Inc, Andover, MA USA
[4] Pfizer Inc, Cambridge, MA USA
[5] Pfizer Pharma GmbH, Berlin, Germany
[6] Pfizer Ltd, Walton Oaks, England
[7] Pfizer Inc, Groton, CT 06340 USA
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
628
引用
收藏
页码：S305 / S305
页数：1
相关论文
共 50 条
  • [1] Efficacy of ertugliflozin in monotherapy or combination therapy in patients with type 2 diabetes: A pooled analysis of placebo-controlled studies
    Liu, Jie
    Tarasenko, Lisa
    Terra, Steven G.
    Huyck, Susan
    Wu, Larry
    Pong, Annpey
    Calle, Roberto A.
    Gallo, Silvina
    Darekar, Amanda
    Mancuso, James P.
    DIABETES & VASCULAR DISEASE RESEARCH, 2019, 16 (05): : 415 - 423
  • [2] Ertugliflozin effectively improves glycaemic control as monotherapy in patients with type 2 diabetes: the VERTIS MONO trial
    Terra, S.
    Davies, M. J.
    Frias, J.
    Derosa, G.
    Darekar, A.
    Focht, K.
    Golm, G.
    Johnson, J.
    Saur, D.
    Dagogo-Jack, S.
    DIABETOLOGIA, 2016, 59 : S346 - S346
  • [3] WEIGHT CHANGE AND BLOOD PRESSURE, LIPIDS AND GLYCAEMIC CONTROL AMONG PATIENTS WITH TYPE 2 DIABETES
    Janghorbani, M.
    Amini, M.
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2011, 65 : A255 - A255
  • [4] Effect of ertugliflozin on glucose control, body weight, blood pressure and bone density in type 2 diabetes mellitus inadequately controlled on metformin monotherapy (VERTIS MET)
    Rosenstock, Julio
    Frias, Juan
    Pall, Denes
    Charbonnel, Bernard
    Pascu, Raluca
    Saur, Didier
    Darekar, Amanda
    Huyck, Susan
    Shi, Harry
    Lauring, Brett
    Terra, Steven G.
    DIABETES OBESITY & METABOLISM, 2018, 20 (03): : 520 - 529
  • [5] Effect of ertugliflozin on glycemic levels, blood pressure and body weight of patients with type 2 diabetes mellitus: a systematic review and meta-analysis
    Zaman, Maryam
    Memon, Roha Saeed
    Amjad, Arooba
    Rizwan, Tehlil
    Kumar, Jai
    ul Haque, Ibtehaj
    Ali, Syed Saad
    Li, Lin
    Usman, Muhammad Shariq
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2020, 19 (02) : 1873 - 1878
  • [6] Effect of ertugliflozin on blood pressure in patients with type 2 diabetes mellitus: a post hoc pooled analysis of randomized controlled trials
    Liu, Jie
    Pong, Annpey
    Gallo, Silvina
    Darekar, Amanda
    Terra, Steven G.
    CARDIOVASCULAR DIABETOLOGY, 2019, 18 (1)
  • [7] EFFECTS OF ERTUGLIFLOZIN ON BLOOD PRESSURE AND PULSE RATE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Liu, Jie
    Pong, Annpey
    Gallo, Silvina
    Darekar, Amanda
    Terra, Steven
    Lauring, Brett
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1810 - 1810
  • [8] Effect of ertugliflozin on blood pressure in patients with type 2 diabetes mellitus: a post hoc pooled analysis of randomized controlled trials
    Jie Liu
    Annpey Pong
    Silvina Gallo
    Amanda Darekar
    Steven G. Terra
    Cardiovascular Diabetology, 18
  • [9] Effect of ertugliflozin on glycemic levels, blood pressure and body weight of patients with type 2 diabetes mellitus: a systematic review and meta-analysis
    Maryam Zaman
    Roha Saeed Memon
    Arooba Amjad
    Tehlil Rizwan
    Jai Kumar
    Ibtehaj ul Haque
    Syed Saad Ali
    Lin Li
    Muhammad Shariq Usman
    Journal of Diabetes & Metabolic Disorders, 2020, 19 : 1873 - 1878
  • [10] Sitagliptin Monotherapy improved glycaemic control in patients with type 2 diabetes
    Aschner, P.
    Kipnes, M.
    Lunceford, J.
    Sanchez, M.
    Mickel, C.
    Davies, M. J.
    Williams-Herman, D.
    DIABETOLOGIA, 2006, 49 : 5 - 5
12345